Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Evaluation of the following prognostic factors in France, based on national quotation data: volume per center, patient age, geographic distance from a clinical center, delay for chemotherapy,Upfront surgery.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| To study the prognostic effect of the volume of activity | To study the prognostic effect of the volume of activity per center on the risk of recurrence | at 5 years |
| Verify that the therapeutic sequence | Verify that the therapeutic sequence of primary surgery and secondary chemotherapy is a good prognostic factor for overall and specific survival at 5 years | at 5 years |
| Measure | Description | Time Frame |
|---|---|---|
| Verify that delay in initiation of chemotherapy beyond 4 weeks | Verify that delay in initiation of chemotherapy beyond 4 weeks after surgery is a poor prognostic element on overall and specific survival at 5 years | at 5 years |
| Verify that age is a poor prognostic element |
Not provided
Inclusion criteria:
Exclusion criteria:
Not provided
Not provided
Not provided
Women treated for tubo-ovarian cancer in France between 2012 and 2016
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Martha DURAES, Md | University Hospital, Montpellier | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Uhmontpellier | Montpellier | 34295 | France |
NC
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D010051 | Ovarian Neoplasms |
| ID | Term |
|---|---|
| D004701 | Endocrine Gland Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D010049 | Ovarian Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Verify that age is a poor prognostic element for overall and specific survival at 5 years |
| at 5 years |
| Verify that geographic distance | Verify that geographic distance from a clinical center is a poor prognostic element for overall and specific survival at 5 years | at 5 years |
| D000291 |
| Adnexal Diseases |
| D005831 | Genital Diseases, Female |
| D052776 | Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D005833 | Genital Neoplasms, Female |
| D014565 | Urogenital Neoplasms |
| D000091662 | Genital Diseases |
| D004700 | Endocrine System Diseases |
| D006058 | Gonadal Disorders |